On the contrary, the common adverse events in the A+B patients were elevated AST (38.1%), elevated ALT (27.4%), anorexia (11.9%), proteinuria (11.9%), esophageal variceal bleeding (EVB) (10.7%). This evidence concerns the gene GPT and esophageal varices.